“A Comprehensive Diagnostic Offering Workflow Increases the Rate of Actionable Results of the 23- and 35-Gene Expression Profile Tests for Use As Ancillary Diagnostic Tools for Difficult-to-Diagnose Melanocytic Lesions”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s79. Accessed April 21, 2026. https://skin.dermsquared.com/skin/article/view/1430.